Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “SPERO THERAPEUTICS, INC.”

7 pharma patents match "SPERO THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "SPERO THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “SPERO THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 12226403

    Tebipenem pivoxil immediate and modified release oral dosage forms

    SPERO THERAPEUTICS, INC. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  2. US 12146004

    Polymyxin compounds and uses thereof

    SPERO THERAPEUTICS, INC. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  3. US 12098155

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Sep 24, 2024 · Expires Sep 19, 2044

    granted
  4. US 12048691

    High dosage tebipenem pivoxil tablet formulation

    SPERO THERAPEUTICS, INC. · Granted Jul 30, 2024 · Expires Jul 25, 2044

    granted
  5. US 11718621

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  6. US 11459357

    Polymyxin compounds

    SPERO THERAPEUTICS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  7. US 10889587

    Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

    SPERO THERAPEUTICS, INC. · Granted Jan 12, 2021 · Expires Jan 7, 2041

    granted